Displaying drugs 51 - 75 of 135 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00005 |
Etanercept
185243-69-0 |
51234.9000 C2224H3475N621O698S36 |
|
Antirheumatic Agents / Immunomodulatory Agents | For treatment of severe active rheumatoid arthritis in adults, severe juvenile idiopathic arthritis, ankylosing spondylitis, and severe plaque psor... |
| DB01276 |
Exenatide
141758-74-9 |
4186.6000 C184H282N50O60S |
|
Indicated as adjunctive therapy to improve glycemic control in patients with Type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or ... | |
| DB00093 |
Felypressin
56-59-7 |
1040.2190 C46H65N13O11S2 |
|
Renal Agents / Vasoconstrictor Agents | For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential. |
| DB00099 |
Filgrastim
143011-72-7 |
18802.8000 C845H1343N223O243S9 |
|
Anti-Infective Agents / Antineutropenic Agents / Immunomodulatory Agents | Increases leukocyte production, for treatment in non-myeloid cancer, neutropenia and bone marrow transplant. |
| DB00066 |
Follitropin beta
9002-68-0 |
22672.9000 C975H1513N267O304S26 |
|
Fertility Agents | For treatment of female infertility |
| DB01279 |
Galsulfase
552858-79-4 |
56000.0000 C2534H3851N691O719S16 |
|
Enzyme Replacement Agents | For the treatment of adults and children with Mucopolysaccharidosis VI. |
| DB00056 |
Gemtuzumab ozogamicin
220578-59-6 |
|
Antineoplastic Agents | For treatment of CD33-positive acute myeloid leukemia in patients 60 and over who are not candidates for other chemotherapy. | |
| DB05259 |
Glatiramer Acetate
147245-92-9 |
623.6505 C25H45N5O13 |
|
Adjuvants, Immunologic / Immunosuppressive Agents | For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis. |
| DB00040 |
Glucagon recombinant
9007-92-5 |
3767.1000 C165H249N49O51S1 |
|
Antihypoglycemic Agents | For treatment of severe hypoglycemia, also used in gastrointestinal imaging |
| DB00027 |
Gramicidin D
1405-97-6 |
1882.2947 C99H140N20O17 |
|
Anti-Infectives / Antibiotic Agents / Ophthalmic Antibiotic / Topical Antibiotic / Antibiotics | For treatment of skin lesions, surface wounds and eye infections |
| DB00062 |
Human Serum Albumin
9048-49-1 |
66472.2000 C2936H4624N786O889S41 |
|
Serum substitutes | For treatment of severe blood loss, hypervolemia, hypoproteinemia |
| DB00070 |
Hyaluronidase
488712-31-8 |
53870.9000 C2455H3775N617O704S21 |
|
Anesthetic Adjuvants / Permeabilizing Agents | For increase of absorption and distribution of other injected drugs and for rehydration. |
| DB00078 |
Ibritumomab
174722-31-7 |
143375.5000 C6382H9830N1672O1979S54 |
|
Antineoplastic Agents | For treatment of non-Hodgkin's lymphoma |
| DB01271 |
Idursulfase
50936-59-9 |
76000.0000 C2654H4000N688O774S14 |
|
Enzyme Replacement Agents | For the treatment of Hunter syndrome in adults and children ages 5 and older. |
| DB00053 |
Imiglucerase
143003-46-7 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB00065 |
Infliximab
170277-31-3 |
144190.3000 C6428H9912N1694O1987S46 |
|
Immunomodulatory Agents / Immunosuppressive Agents | To manage the signs and symptoms, as well as to induce and maintain clinical remission in adults with moderate to severe active Crohn's disease or ... |
| DB01306 |
Insulin Aspart
116094-23-6 |
C256H381N65O79S6 |
|
Antidiabetic / Hypoglycemic Agents | For the treatment of Type 1 or 2 diabetes mellitus. Should normally be used in conjunction with an intermediate or long-acting insulin. |
| DB01307 |
Insulin Detemir
169148-63-4 |
C267H402N64O76S6 |
|
Antidiabetic / Hypoglycemic Agents | For the treatment of type 1 or 2 diabetes mellitus. May be used in combination with oral anti-diabetic agents in type 2 diabetic patients who are n... |
| DB00047 |
Insulin Glargine
160337-95-1 |
6063.0000 C267H408N72O77S6 |
|
Antidiabetic / Hypoglycemic Agents | For the treatment of Type 1 or 2 diabetes mellitus in patients over 17 years old who require a long-acting (basal) insulin for the control of hyper... |
| DB01309 |
Insulin Glulisine
207748-29-6 |
C258H384N64O78S6 |
|
Antidiabetic / Hypoglycemic Agents | For the treatment of Type 1 and 2 diabetes mellitus. Should be used in regimens including a long-acting or basal insulin analogue unless it is used... |
| DB00046 |
Insulin Lispro
133107-64-9 |
5808.0000 C257H387N65O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a con... |
| DB00030 |
Insulin recombinant
9004-10-8 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For treatment of Type I and II diabetes mellitus. |
| DB00071 |
Insulin, porcine
9004-14-2 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For the treatment of type I and II diabetes mellitus. |
| DB00034 |
Interferon Alfa-2a, Recombinant
77907-69-8 |
19241.1000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Antiviral Agents | For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatm... |
| DB00105 |
Interferon Alfa-2b, Recombinant
99210-65-8 |
19271.0000 C860H1353N229O255S9 |
|
Antineoplastic Agents / Antiviral Agents / Immunomodulatory Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
Displaying drugs 51 - 75 of 135 in total